Is LAMY halal to invest in?

According to Musaffa's Shariah screening methodology, LAMY (LMMY) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is LAMY a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes LAMY using these criteria to determine its compliance status.

Can Muslims buy shares of LAMY?

Muslim investors may consider investing in LAMY if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is LAMY classified as NOT COVERED?

Musaffa determines the Shariah status of LAMY by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for LAMY updated?

The Shariah compliance status of LAMY may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like LAMY become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of LAMY?

You can check the latest Shariah compliance status of LAMY on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

LAMY. Stock Analysis LMMY

United States N/A Nano Cap

LAMY engages in developing a business tapping the eLearning market and the gaming market by teaching financial knowledge and resource management to children. The company is headquartered in St. Petersburg, Florida. The company went IPO on 2024-04-30. The firm is engaged in developing and manufacturing mammalian and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The platform enables the custom production of exosomes with genetic functionality, capable of selectively targeting specific cells to address diseases with unmet medical needs. The engineered exosomes have demonstrated the potential to target cancer stem cells, the primary drivers of recurrence and metastasis in various cancers, including glioblastoma and pancreatic cancer. Its proprietary manufacturing process utilizes plant-based materials to create exosomes used in various commercial applications, including dermatology and dentistry.

Key Statistics of LAMY (LMMY)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.47$0.47

Today's Open

$0.47

Volume

1061.00

P/E Ratio (TTM)

52 Week Range

$0.06$0.94

Market Cap

28.66M

Avg. Volume

2433.40

Dividend Yield

Financial Metrics & Statements of LAMY (LMMY)

FAQ's for LAMY (LMMY)

According to Musaffa’s Shariah screening methodology, LAMY (LMMY) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.